Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside?
Onorati F, Chen-Scarabelli C, Knight R, Stephanou A, Mohanti B, Santini F, Tessari M, Kini A, Narula J, Saravolatz L, Mazzucco A, Scarabelli T, Faggian G.
Onorati F, et al. Among authors: faggian g.
Cardiovasc Drugs Ther. 2013 Oct;27(5):451-63. doi: 10.1007/s10557-013-6468-7.
Cardiovasc Drugs Ther. 2013.
PMID: 23824484
Review.